Inventor · disambiguated record
David Crockford
Also filed as: CROCKFORD DAVID · CROCKFORD DAVID R · CROCKFORD DAVID ROE
14 granted patents·11 pending applications·465 citations·filing 1979–2019
93Inventor score
Files withREGENERX BIOPHARMACEUTICALS6REGENERX BIOPHARMACEUTICALS INC4CROCKFORD DAVID3NUC MED INC3CROCKFORD DAVID ROE2
Top patents by PatentIndex Score
25 records- 0195US4323546AMethod and composition for cancer detection in humansNUC MED INC·Filed 1979·Granted Apr 6, 1982·141 cites·12 claims
- 0291US8093214B2Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failureCROCKFORD DAVID·Filed 2006·Granted Jan 10, 2012·12 cites·15 claims
- 0391US4311688AComposition and method for cancer detection in humansSERONO LAB·Filed 1979·Granted Jan 19, 1982·58 cites·14 claims
- 0490US4424200AMethod for radiolabeling proteins with technetium-99mNUC MED INC·Filed 1981·Granted Jan 3, 1984·90 cites·17 claims
- 0587US4472371ARadiolabeled antibody to anti-tumor associated antigen and processSUMMA MEDICAL CORP·Filed 1982·Granted Sep 18, 1984·64 cites·34 claims
- 0684US8464706B2Drug delivery apparatusCROCKFORD DAVID ROE·Filed 2001·Granted Jun 18, 2013·30 cites·2 claims
- 0784US4478815AComposition and method for detecting cancer with technetium labeled antibody fragmentsNUC MED INC·Filed 1981·Granted Oct 23, 1984·55 cites·13 claims
- 0876US8383576B2LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilizedREGENERX BIOPHARMACEUTICALS·Filed 2006·Granted Feb 26, 2013·3 cites·6 claims
- 0973US9585941B2Eye drop formulationREGENERX BIOPHARMACEUTICALS INC·Filed 2016·Granted Mar 7, 2017·1 cites·10 claims
- 1072US8426365B2Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failureCROCKFORD DAVID·Filed 2011·Granted Apr 23, 2013·2 cites·18 claims
- 1163US10004785B2LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilizedREGENERX BIOPHARMACEUTICALS INC·Filed 2017·Granted Jun 26, 2018·0 cites·15 claims
- 1259US9821030B2LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilizedCROCKFORD DAVID·Filed 2011·Granted Nov 21, 2017·0 cites·13 claims
- 1359US2010215583A1Cell nucleus-entering compositionsREGENRX BIOPHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1458US2017128540A1Eye drop formulationREGENERX BIOPHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1557US2011172155A1Beta thymosin fragmentsREGENERX BIOPHARMACEUTICALS·Filed 2009·Application pending·0 cites
- 1656US2016287673A1Compositions and methods for treating corneal epithelial woundREGENERX BIOPHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1751US8820316B2Drug delivery apparatusCROCKFORD DAVID ROE·Filed 2004·Granted Sep 2, 2014·9 cites·14 claims
- 1849US2006100156A1Cell nucleus-entering compositionsUNIV ERLANGEN NUERNBERG·Filed 2005·Application pending·0 cites
- 1948US2013196912A1Beta thymosin fragmentsREGENERX BIOPHARMACEUTICALS·Filed 2013·Application pending·0 cites
- 2048US2008051348A1Treatment of infections and other disordersREGENERX BIOPHARMACEUTICALS·Filed 2007·Application pending·0 cites
- 2147US2008248993A1Modified Beta Thymosin PeptidesREGENERX BIOPHARMACEUTICALS·Filed 2006·Application pending·0 cites
- 2242US2006120971A1Agents and methods for administration to the central nervous systemSIGNUM PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2340US2015203561A1Beta thymosin fragmentsREGENERX BIOPHARMACEUTICALS·Filed 2015·Application pending·0 cites
- 2440US2019201377A1Methods and compositions for treatment of lipid storage disordersNEUROTROPE BIOSCIENCE INC·Filed 2019·Application pending·0 cites
- 2538US9724328B2Methods and compositions for treatment of lipid storage disordersNEUROTROPE BIOSCIENCE·Filed 2015·Granted Aug 8, 2017·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when David Crockford files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →